FDA Alerts
First Generic Abilify Approved
The U.S. Food and Drug Administration today approved the first generic versions of Abilify (aripiprazole).
FDA Warns of Rare but Serious Skin Reactions from Ziprasidone
FDA is warning that the antipsychotic drug ziprasidone (marketed under the brand name, Geodon, and its generics) is associated with a rare but serious skin reaction that can progress to affect other parts of the body.
FDA Approves First Generic Olanzapine
The U.S. Food and Drug Administration today approved the first generic versions of Zyprexa ( olanzapine tablets) and Zyprexa Zydus ( olanzapine orally disintegrating tablets) to treat schizophrenia and bipolar disorder.
FDA Drug Safety Communication: Saphris
The U.S. Food and Drug Administration (FDA) is warning the public that serious allergic reactions have been reported with the use of the antipsychotic medication Saphris ( asenapine maleate ).
Risperdal (risperidone) and Risperidone Recall
Ortho-McNeil-Janssen Pharmaceuticals notified healthcare professionals and the public of a recall of specific lots of Risperdal ( risperidone ) 3mg tablets and risperidone 2mg tablets.
Medication Errors Resulting From Name Confusion
The U.S. Food and Drug Administration (FDA) is alerting the public to medication error reports in which patients were given risperidone ( Risperdal ) instead of ropinirole ( Requip ) and vice versa. In some cases, patients who took the wrong medication needed to be hospitalized.
Motherhood is About to Make You a Little Crazier
FDA notified healthcare professionals that the Pregnancy section of drug labels for the entire class of antipsychotic drugs has been updated.